TECHNOLOGY DEV COMPANY LTD has a total of 32 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and medical technology are RAKEPOLL HOLDING B V, ALIATROS MEDICAL AS and PHOENIX U S A INC LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Norway | 3 | |
#7 | South Africa | 3 | |
#8 | Argentina | 2 | |
#9 | Brazil | 2 | |
#10 | Taiwan | 2 | |
#11 | United States | 2 | |
#12 | Chile | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Polysaccharides | |
#5 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Sabetsky Vladimir | 21 |
#2 | Vladimir Sabetsky | 6 |
#3 | Sabetsky Wladimir | 2 |
#4 | Sabetsky Vladimir Andreevich | 1 |
Publication | Filing date | Title |
---|---|---|
TW200603843A | Tissue enhancement implant and method | |
CA2518148A1 | Long acting injectable insulin composition and methods of making and using thereof | |
ZA200508022B | Oral insulin composition and methods of making and using thereof |